Adocia | Key People and Executives

Gérard Soula
Chairman & Chief Executive Officer
Olivier Soula
Director, Director-R&D, Deputy CEO
Laurent Arthaud
Director
Olivier Martinez
Director
Gérard Soula
Chairman & Chief Executive Officer
Martin Gaudier
Director-Scientific
Stanislav Glezer
Director-Medical
Olivier Soula
Director, Director-R&D, Deputy CEO
Laurent Arthaud
Director
Olivier Martinez
Director
Géraldine Favre-Soula
Director-Human Resources Development

About Adocia

View Profile
Address
115 avenue Lacassagne
Lyon Rhone-Alpes 69003
France
Employees -
Website http://www.adocia.com
Updated 07/08/2019
Adocia SA is a clinical-stage biotechnology company, which engages in the development of medicines from already-approved therapeutic proteins and peptides. Its product pipelines include: BioChaperone Lispro; BioChaperone Combo; HinsBet; BioChaperone Human Glucagon; BioChaperone Glargine GLP-1; and BioChaperone Prandaial Combinations for T1D. The company was founded by Gérard, Olivier, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.